Toprol
Product Images NDC 71610-373

4 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Toprol (NDC 71610-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 200 mg (71610 0373 45)

Bottle Label 200 mg (71610 0373 45)
Label for Metoprolol Succinate (Toprol XL) ER 200 mg tablets, 45 count. The label includes storage instructions to keep between 20-25 degrees Celsius, dispensing guidance, manufacturer information (AstraZeneca AB, Sodertalje, Sweden), and repackager details (Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN). It also notes the product is prescription only (RX Only).*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram shown for the active ingredients in TOPROL XL, including a detailed structural formula with hydroxyl, ether, amine, and aromatic groups, and a separate structure for an acid component, likely representing the drug's salt form.*
FDA Label Image

Merit Results Graph (Image 02)

Merit Results Graph (Image 02)
A forest plot chart showing comparative relative risk and 95% confidence intervals for various subgroups in the MERIT-HE study. The subgroups are analyzed for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure, comparing TOPROL-XL versus placebo. Subgroups include geography (US, Non-US), NYHA class, ejection fraction categories, ischemic vs. non-ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension history, and heart rate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.